Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check5 days agoChange DetectedThe study page now includes new related topics: Multiple myeloma and MedlinePlus Genetics, updating its categorization and linkage to disease and genetics resources.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page now shows a different site revision identifier (v3.5.3 instead of v3.5.2) and the associated “related topics” section content appears to have been adjusted. This does not change the trial’s study details or scientific/participant-relevant information.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page now includes the 'Multiple myeloma' tag and a MedlinePlus Genetics related topics link, and the revision version was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRemoved the 'Multiple myeloma' condition and the 'MedlinePlus Genetics' related topics from the study page.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics' and updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; the old revision badge was removed and the new one added.SummaryDifference0.0%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.